The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM

NCT02844309 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Waldenström Macroglobulinemia

Interventions

DRUG: Thalidomide

Sponsor

Institute of Hematology & Blood Diseases Hospital, China